Metraipolis › archive › dc_7ecdd239bcad

Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching — Europe PMC PMID:41681960

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41681960
DOI
10.3390/cancers18030488
License (as archived)
solo-consultazione
Archived
2026-11-06T09:20:55.359Z
SHA-256 of the archived text
45191737446898543c9eee85046ffccf59689bd964be28983871a736e81f0e6f
Stable URL of this page
https://metraipolis.com/documento/dc_7ecdd239bcad

How to cite

Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching — Europe PMC PMID:41681960 — Europe PMC (en), https://europepmc.org/article/MED/41681960 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ecdd239bcad (Metraipolis archive dc_7ecdd239bcad, sha256 45191737446898543c9eee85046ffccf59689bd964be28983871a736e81f0e6f)
BibTeX
@misc{dc7ecdd239bcad,
  title = {Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching — Europe PMC PMID:41681960},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41681960},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ecdd239bcad; sha256 45191737446898543c9eee85046ffccf59689bd964be28983871a736e81f0e6f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41681960. Agents can read the archived copy with the MCP tool read_document.